Institution statistics

PFIZER LIMITED - United Kingdom

Ranking results:

Past rankings:

2019
Total Number of Projects:	200-300
Networking Rank (Reputation):	> 1000
2018
Criterium:	Position:
Overall Score:	800-900
Total Number of Projects:	300-400
Networking Rank (Reputation):	> 1000
2015
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2011
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 33
As coordinator: 0
As participant: 33
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2020	0	23.790.694	0		2
2019	0	196.939.080	0		13
2018	0	103.838.674	0		7
2017	0	66.023.667	0		8
2016	0	14.080.000	0		2
2008	0	2.908.693	290.869		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
NOVARTIS PHARMA	22
JANSSEN PHARMACEUTICA NV	19
UCB BIOPHARMA	15
ELI LILLY AND COMPANY LIMITED	13
F HOFFMANNLA ROCHE	12
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	11
SANOFIAVENTIS	11
NOVO NORDISK	10
TAKEDA DEVELOPMENT CENTRE EUROPE	10
BAYER AKTIENGESELLSCHAFT	9
KATHOLIEKE UNIVERSITEIT LEUVEN	8
MERCK SHARP & DOHME CORP	8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	8
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	8
UNIVERSITY OF NEWCASTLE UPON TYNE	8
ABBVIE INC	7
EUROPEAN PATIENTS' FORUM	7
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	7
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT	7
ACADEMISCH ZIEKENHUIS GRONINGEN	6
ASTRAZENECA	6
ASTRAZENECA AB	6
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	6
CHARITE UNIVERSITAETSMEDIZIN BERLIN	6
KAROLINSKA INSTITUTE	6
STICHTING KATHOLIEKE UNIVERSITEIT	6
THE UNIVERSITY OF MANCHESTER	6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	5
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER	5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	5
MEDIZINISCHE UNIVERSITAET WIEN	5
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN	5
SANOFIAVENTIS DEUTSCHLAND	5
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	5
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE	5
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM	4
BAYER	4
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE	4
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	4
STICHTING VUMC	4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	4
THE UNIVERSITY OF LIVERPOOL	4
UNIVERSITAET ZUERICH	4
UNIVERSITY COLLEGE LONDON	4
UPPSALA UNIVERSITET	4
ACADEMISCH ZIEKENHUIS LEIDEN	3
ALLERGAN LIMITED	3
AMGEN LIMITED	3
ANTAROS MEDICAL AB	3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	3
BRISTOLMYERS SQUIBB COMPANY CORP	3
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL	3
EBERHARD KARLS UNIVERSITAET TUEBINGEN	3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK	3
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE	3
EUROPEAN CANCER PATIENT COALITION	3
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES	3
FUJIFILM CELLULAR DYNAMICS INC	3
FUNDACIO SANT JOAN DE DEU	3
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA	3
GLAXOSMITHKLINE BIOLOGICALS	3
H LUNDBECK AS	3
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE	3
IXSCIENT LIMITED	3
KING'S COLLEGE LONDON	3
LEIDS UNIVERSITAIR MEDISCH CENTRUM	3
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU	3
SERVICIO ANDALUZ DE SALUD	3
TARTU ULIKOOL	3
THE UNIVERSITY OF SHEFFIELD	3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT	3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ	3
UNIVERSITAT WIEN	3
UNIVERSITATSKLINIKUM ERLANGEN	3
UNIVERSITY OF BIRMINGHAM	3
UNIVERSITY OF BOLOGNA	3
UNIVERSITY OF COPENHAGEN	3
UNIVERSITY OF DUNDEE	3
UNIVERSITY OF GLASGOW	3
VIB	3
ACADEMIC MEDICAL CENTRE AMSTERDAM	2
AUSTRIAN RESEARCH CENTERS SIEBERDORF	2
BAYER PHARMA	2
BIOMERIEUX	2
CELGENE MANAGEMENT SARL	2
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY	2
CONCENTRIS RESEARCH MANAGEMENT	2
COVANCE LABORATORIES	2
CSL BEHRING	2
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN	2
DREEM	2
ELLEGAARD GOTTINGEN MINIPIGS AS	2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS	2
EUROPEAN AIDS TREATMENT GROUP EV	2
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING	2
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS	2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION	2
FOLKEHELSEINSTITUTTET	2
FONDAZIONE PENTA FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES ONLUS	2
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA	2

Constancy:

Total number of partners:897

Partner loyalty:
Frequent Partner: (> 2 projects): 433
Rare Partner: 464

Frequent / Rare Partner Ratio: 0.93

Diversity:

Subjects:

Subject:	No:
MEDICINE	1
MEDICAL BIOTECHNOLOGY	1
HEALTH	1
MEDICINE, HEALTH	1

Diversity index:1

Categories:

Category:	No:
BIOLOGICAL SCIENCES	1

Project overview:

Start date	Project	acronym	role	funding	partners
2020-01-01	PharmaLedger	PharmaLedger	participant	8.290.694	28
2020-01-01	Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies	ImmUniverse	participant	15.500.000	26
2019-11-01	EU Patient- cEntric clinicAl tRial pLatform	EU-PEARL	participant	12.004.953	36
2019-11-01	Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases	IDEA-FAST	participant	20.997.523	46
2019-10-01	Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies	Immune-Image	participant	15.000.000	22
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	31
2019-09-01	Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions	3TR	participant	40.273.192	70
2019-04-01	Biomarkers in Atopic Dermatitis and Psoriasis	BIOMAP	participant	10.500.000	32
2019-04-01	Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation	ConcePTION	participant	15.299.991	51
2019-04-01	Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement	MOBILISE-D	participant	25.395.897	34
2019-03-01	EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells	EBiSC2	participant	4.599.648	16
2019-03-01	Neurotoxicity De-Risking in Preclinical Drug Discovery	NeuroDeRisk	participant	5.331.000	18
2019-02-01	Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease	TransBioLine	participant	13.999.998	27
2019-01-01	Vaccines and Infectious Diseases in the Ageing PopuLation	VITAL	participant	5.499.882	24
2019-01-01	Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain	IM2PACT	participant	9.000.000	27
2018-11-01	European Health Data and Evidence Network	EHDEN	participant	14.105.750	22
2018-09-01	Ensuring the future of EUPATI beyond 2020	EFOEUPATI	participant	365.243	12
2018-09-01	WEB-RADR 2	WEB-RADR 2	participant	1.168.750	11
2018-07-01	Research empowerment on solute carriers (ReSOLUTE)	ReSOLUTE	participant	12.000.000	14
2018-05-01	conect4children (COllaborative Network for European Clinical Trials For Children)	c4c	participant	67.000.000	48
2018-05-01	Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production	iConsensus	participant	4.700.000	19
2018-03-01	Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.	PARADIGM	participant	4.498.931	34
2017-11-01	Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections	COMBACTE-CDI	participant	2.312.305	14
2017-11-01	Liver Investigation: Testing Marker Utility in Steatohepatitis	LITMUS	participant	15.797.881	56
2017-10-01	European Quality In Preclinical Data	EQIPD	participant	4.495.523	30
2017-09-01	Rheuma Tolerance for Cure	RTCure	participant	6.000.000	20
2017-02-01	Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055	DO-IT	participant	3.549.833	36
2017-01-01	REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019	RESCEU	participant	14.498.125	18
2017-01-01	ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064	ITCC-P4	participant	7.370.000	21
2017-01-01	Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106	IB4SD-TRISTAN	participant	12.000.000	21
2016-10-01	Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966	PREFER	participant	6.000.000	33
2016-04-01	Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916	PRISM	participant	8.080.000	23
2008-12-01	Combating incontinence, from basic science to clinical practice	INCOMB	participant	2.908.693	10

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum